132 related articles for article (PubMed ID: 36745103)
1. TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia.
Sakoda T; Kikushige Y; Miyamoto T; Irifune H; Harada T; Hatakeyama K; Kunisaki Y; Kato K; Akashi K
Blood Adv; 2023 May; 7(10):2053-2065. PubMed ID: 36745103
[TBL] [Abstract][Full Text] [Related]
2. [TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in human acute myeloid leukemia].
Sakoda T; Kikushige Y
Rinsho Ketsueki; 2023; 64(6):547-552. PubMed ID: 37407480
[TBL] [Abstract][Full Text] [Related]
3. Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapy.
Kikushige Y
Blood Cell Ther; 2022 Dec; 5(Spec Edition):S1-S5. PubMed ID: 37220607
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia.
Wu Z; Ou J; Liu N; Wang Z; Chen J; Cai Z; Liu X; Yu X; Dai M; Zhou H
Cancer Med; 2023 Apr; 12(7):8956-8969. PubMed ID: 36545697
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia.
Huang W; Zheng S; Wang Q; Zhao N; Long Z
Sci Rep; 2023 Sep; 13(1):15658. PubMed ID: 37730831
[TBL] [Abstract][Full Text] [Related]
6. IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways.
Naef P; Radpour R; Jaeger-Ruckstuhl CA; Bodmer N; Baerlocher GM; Doehner H; Doehner K; Riether C; Ochsenbein AF
Sci Signal; 2023 Aug; 16(800):eadd7705. PubMed ID: 37643244
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses.
Láinez-González D; Alonso-Aguado AB; Alonso-Dominguez JM
Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237497
[TBL] [Abstract][Full Text] [Related]
8. Wnt regulation of hematopoietic stem cell development and disease.
Carpenter KA; Thurlow KE; Craig SEL; Grainger S
Curr Top Dev Biol; 2023; 153():255-279. PubMed ID: 36967197
[TBL] [Abstract][Full Text] [Related]
9. TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines.
Rezaei M; Ghanadian M; Ghezelbash B; Shokouhi A; Bazhin AV; Zamyatnin AA; Ganjalikhani-Hakemi M
Front Immunol; 2023; 14():1267578. PubMed ID: 38022614
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia.
Al-Hamaly MA; Cox AH; Haney MG; Zhang W; Arvin EC; Sampathi S; Wimsett M; Liu C; Blackburn JS
Biomed Pharmacother; 2024 Jan; 170():116013. PubMed ID: 38104416
[TBL] [Abstract][Full Text] [Related]
11. Cordycepin (3'dA) Induces Cell Death of AC133
Abazari N; Stefanucci MR; Bossi LE; Trojani A; Cairoli R; Beghini A
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568748
[TBL] [Abstract][Full Text] [Related]
12. CRIP1 supports the growth and migration of AML-M5 subtype cells by activating Wnt/β-catenin pathway.
Deng X; Zeng Y; Qiu X; Zhong M; Xiong X; Luo M; Zhang J; Chen X
Leuk Res; 2023 Jul; 130():107312. PubMed ID: 37224580
[TBL] [Abstract][Full Text] [Related]
13. ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification.
Ye W; Wang J; Huang J; He X; Ma Z; Li X; Huang X; Li F; Huang S; Pan J; Jin J; Ling Q; Wang Y; Yu Y; Sun J; Jin J
Front Med; 2023 Aug; 17(4):685-698. PubMed ID: 37131085
[TBL] [Abstract][Full Text] [Related]
14. HMGB1-mediated transcriptional activation of circadian gene TIMELESS contributes to endometrial cancer progression through Wnt-β-catenin pathway.
Wang Z; He S; Xin L; Zhou Y; Zhao L; Wang F
Cell Signal; 2024 Apr; 116():111045. PubMed ID: 38211843
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Small-Molecule TIM-3 Inhibitors for Acute Myeloid Leukemia Using Pharmacophore-Based Virtual Screening.
Abdel-Rahman SA; Talagayev V; Pach S; Wolber G; Gabr MT
J Med Chem; 2023 Aug; 66(16):11464-11475. PubMed ID: 37566998
[TBL] [Abstract][Full Text] [Related]
16. Zebrafish Drug Screening Identifies Erlotinib as an Inhibitor of Wnt/β-Catenin Signaling and Self-Renewal in T-cell Acute Lymphoblastic Leukemia.
Al-Hamaly MA; Cox AH; Haney MG; Zhang W; Arvin EC; Sampathi S; Wimsett M; Liu C; Blackburn JS
bioRxiv; 2023 Aug; ():. PubMed ID: 37693603
[TBL] [Abstract][Full Text] [Related]
17. Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting.
Tan J; Tan H; Li Y
Exp Hematol Oncol; 2023 Jul; 12(1):62. PubMed ID: 37468979
[TBL] [Abstract][Full Text] [Related]
18. WNT Signaling in Stem Cells: A Look into the Non-Canonical Pathway.
Sarabia-Sánchez MA; Robles-Flores M
Stem Cell Rev Rep; 2024 Jan; 20(1):52-66. PubMed ID: 37804416
[TBL] [Abstract][Full Text] [Related]
19. TIM-3: a tumor-associated antigen beyond checkpoint inhibition?
Barth S; Naran K
Immunother Adv; 2022; 2(1):ltac021. PubMed ID: 36406467
[TBL] [Abstract][Full Text] [Related]
20. Signaling pathways governing the behaviors of leukemia stem cells.
Azizidoost S; Nasrolahi A; Sheykhi-Sabzehpoush M; Anbiyaiee A; Khoshnam SE; Farzaneh M; Uddin S
Genes Dis; 2024 Mar; 11(2):830-846. PubMed ID: 37692500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
